Pharmaceutical Industry in China/industry publications
Background:
China has established a complete pharmaceutical industry chain and has become one of the largest pharmaceutical producers in the world. During 2006-2013, the Chinese pharmaceutical industry has been growing at an average annual growth rate of 22.6%, which far outpaces that in other economies in the world, making China the world's fastest growing pharmaceutical market. China was the world's ninth largest drug market in 2007, and it became the third in 2011, following the US and Japan. However, certain problems do exist in the industry, like small-scale capacity, scattered geographical layout, duplicated production processes, lack of patented domestically-developed pharmaceuticals, and outdated manufacturing technology & management structures, reminding investors to act with caution.
China’s position:
China is the third largest pharmaceutical market in the world, only next to the US and Japan.
Purpose of report & value to clients:
To help customers know more about the market situation of pharmaceutical industry in China.
Applicable users:
China’s pharmaceutical industry has developed rapidly during 2006-2013, attaining a CAGR of over 22% in terms of gross industrial output. China’s pharmaceutical industry is projected to keep developing fast in the following years, making China the second largest market in the world at around 2020.
Methodology:
Mainly desk research
China has established a complete pharmaceutical industry chain and has become one of the largest pharmaceutical producers in the world. During 2006-2013, the Chinese pharmaceutical industry has been growing at an average annual growth rate of 22.6%, which far outpaces that in other economies in the world, making China the world's fastest growing pharmaceutical market. China was the world's ninth largest drug market in 2007, and it became the third in 2011, following the US and Japan. However, certain problems do exist in the industry, like small-scale capacity, scattered geographical layout, duplicated production processes, lack of patented domestically-developed pharmaceuticals, and outdated manufacturing technology & management structures, reminding investors to act with caution.
China’s position:
China is the third largest pharmaceutical market in the world, only next to the US and Japan.
Purpose of report & value to clients:
To help customers know more about the market situation of pharmaceutical industry in China.
Applicable users:
- Purchasers of pharmaceuticals out of China;
- Global pharmaceutical producers;
- Investors who want to know more about the conditions of China’s pharmaceutical industry;
- Relevant government regulations
- Key suppliers
- Mergers & acquisitions cases
- Technology R&D
- Drug pricing reform
- Pharmacy trusteeship
China’s pharmaceutical industry has developed rapidly during 2006-2013, attaining a CAGR of over 22% in terms of gross industrial output. China’s pharmaceutical industry is projected to keep developing fast in the following years, making China the second largest market in the world at around 2020.
Methodology:
Mainly desk research
EXECUTIVE SUMMARY
METHODOLOGY
1 BUSINESS ENVIRONMENT
2 EPIDEMIOLOGY AND DISEASE OVERVIEW
3 OVERALL SITUATION
3.1 Key producers
3.2 Export and import
3.3 Domestic circulation
3.4 Technology R&D
4 MARKET STRATEGIES
4.1 Market entry
4.2 Distribution system (including E-commerce)
4.3 Mergers & acquisitions
4.4 Drug pricing reform
4.5 Pharmacy trusteeship
5 SWOT ANALYSIS
6 MARKET OUTLOOK
6.1 Government regulations
6.2 Consumer spending trends
6.3 Hospitals and hospital beds
6.4 Key sub-markets
7 PROFILES OF KEY PHARMACEUTICAL PRODUCERS
7.1 Guangzhou Pharmaceutical Holdings Limited
7.2 Xiuzheng Pharmaceutical Group
7.3 Yangtze River Pharmaceutical Group
7.4 China Resources Pharmaceutical Group Limited
7.5 China National Pharmaceutical Group Corporation
METHODOLOGY
1 BUSINESS ENVIRONMENT
2 EPIDEMIOLOGY AND DISEASE OVERVIEW
3 OVERALL SITUATION
3.1 Key producers
3.2 Export and import
3.3 Domestic circulation
3.4 Technology R&D
4 MARKET STRATEGIES
4.1 Market entry
4.2 Distribution system (including E-commerce)
4.3 Mergers & acquisitions
4.4 Drug pricing reform
4.5 Pharmacy trusteeship
5 SWOT ANALYSIS
6 MARKET OUTLOOK
6.1 Government regulations
6.2 Consumer spending trends
6.3 Hospitals and hospital beds
6.4 Key sub-markets
7 PROFILES OF KEY PHARMACEUTICAL PRODUCERS
7.1 Guangzhou Pharmaceutical Holdings Limited
7.2 Xiuzheng Pharmaceutical Group
7.3 Yangtze River Pharmaceutical Group
7.4 China Resources Pharmaceutical Group Limited
7.5 China National Pharmaceutical Group Corporation
LIST OF TABLES
Table 2-1 Mortality by key disease type in China, 2012
Table 2-2 Mortality (1/100,000) of cardio-cerebrovascular disease in China, 2008-2012
Table 2-3 Number of the infected and death toll for main infectious diseases in China, 2009-2013
Table 2-4 Top 10 cancer of rural area and urban area in China in terms of morbidity, 2010
Table 3.1-1 Top 30 companies of pharmaceutical industry in China in terms of revenue, 2013
Table 3.2-1 Export and import value in the Chinese pharmaceutical industry, 2009-2013, million USD
Table 3.2-2 Export and import value of western medicine in China, 2009-2013, million USD
Table 3.2-3 Export and import value of traditional Chinese medicine in China, 2009-2013, million USD
Table 3.2-4 Export and import value of medical devices in China, 2009-2013, million USD
Table 3.3-1 Revenue of top 30 wholesale medicine enterprises in China, 2013, million USD
Table 3.3-2 Gross sales of top 30 retail medicine enterprises in China, 2013, million USD
Table 4.3-1 Transaction of mergers & acquisitions in pharmaceutical industry in China, 2006-2013
Table 4.3-2 Transaction of mergers & acquisitions in pharmaceutical industry in China by listed companies, 2009-2013
Table 4.3-3 Comparison of M&A at different stages in pharmaceutical industry in China, 2009-2013
Table 4.3-4 Key factors for the first stage M&A (2009-2011) in pharmaceutical industry in China
Table 4.3-5 Key factors for the second stage M&A (2012-2013) in pharmaceutical industry in China
Table 4.4-1 Pricing of different types of drugs in China
Table 6.3-1 Number of healthcare facilities in China, 2009-2013
Table 6.3-2 Number of beds by type of institution in China, 2009-2013
Table 6.3-3 Hospital visits and utilization rate of beds in China, 2009-2013
Table 7.1-1 Basic info of Guangzhou Pharmaceutical Holdings Limited
Table 7.2-1 Basic info of Xiuzheng Pharmaceutical Group
Table 7.3-1 Basic info of Yangtze River Pharmaceutical Group
Table 7.4-1 Basic info of China Resources Pharmaceutical Group Limited
Table 7.5-1 Basic info of China National Pharmaceutical Group Corporation
Table 2-1 Mortality by key disease type in China, 2012
Table 2-2 Mortality (1/100,000) of cardio-cerebrovascular disease in China, 2008-2012
Table 2-3 Number of the infected and death toll for main infectious diseases in China, 2009-2013
Table 2-4 Top 10 cancer of rural area and urban area in China in terms of morbidity, 2010
Table 3.1-1 Top 30 companies of pharmaceutical industry in China in terms of revenue, 2013
Table 3.2-1 Export and import value in the Chinese pharmaceutical industry, 2009-2013, million USD
Table 3.2-2 Export and import value of western medicine in China, 2009-2013, million USD
Table 3.2-3 Export and import value of traditional Chinese medicine in China, 2009-2013, million USD
Table 3.2-4 Export and import value of medical devices in China, 2009-2013, million USD
Table 3.3-1 Revenue of top 30 wholesale medicine enterprises in China, 2013, million USD
Table 3.3-2 Gross sales of top 30 retail medicine enterprises in China, 2013, million USD
Table 4.3-1 Transaction of mergers & acquisitions in pharmaceutical industry in China, 2006-2013
Table 4.3-2 Transaction of mergers & acquisitions in pharmaceutical industry in China by listed companies, 2009-2013
Table 4.3-3 Comparison of M&A at different stages in pharmaceutical industry in China, 2009-2013
Table 4.3-4 Key factors for the first stage M&A (2009-2011) in pharmaceutical industry in China
Table 4.3-5 Key factors for the second stage M&A (2012-2013) in pharmaceutical industry in China
Table 4.4-1 Pricing of different types of drugs in China
Table 6.3-1 Number of healthcare facilities in China, 2009-2013
Table 6.3-2 Number of beds by type of institution in China, 2009-2013
Table 6.3-3 Hospital visits and utilization rate of beds in China, 2009-2013
Table 7.1-1 Basic info of Guangzhou Pharmaceutical Holdings Limited
Table 7.2-1 Basic info of Xiuzheng Pharmaceutical Group
Table 7.3-1 Basic info of Yangtze River Pharmaceutical Group
Table 7.4-1 Basic info of China Resources Pharmaceutical Group Limited
Table 7.5-1 Basic info of China National Pharmaceutical Group Corporation
LIST OF FIGURES
Figure 1-1 China’s GDP and year-on-year growth rate, 2004-2013
Figure 1-2 China’s foreign trade, 2004-2013
Figure 1-3 Total investment in fixed assets in China, 2004-2013
Figure 1-4 Investment in fixed assets under construction and newly built (farmers excluded) in China, 2004-2012
Figure 1-5 Foreign capital actually utilized in China, 2004-2013
Figure 1-6 China’s outward foreign direct investment (financing excluded), 2008-2013
Figure 1-7 China’s population, 2004-2013
Figure 1-8 China’s demographic composition, 2004-2013
Figure 1-9 Per capita income of residents in China, 2004-2013
Figure 1-10 Total health expenditure in China, 2004-2013
Figure 1-11 Per capita health expenditure in China, 2004-2012
Figure 2-1 Morbidity and mortality of infectious diseases in China, 2004-2013
Figure 2-2 Top 10 countries/regions of diabetes in the world in terms of number of diabetic, 2013
Figure 3-1 Gross industrial output of pharmaceutical industry in China, 2006-2013
Figure 3-2 Global pharmaceuticals sales and its growth rate, 2004-2013
Figure 3-3 Structure of gross industrial output of pharmaceutical industry in China, 2013
Figure 3-4 Sales revenue of pharmaceutical industry in China, 2006-2013
Figure 3-5 Profit and profit margin of pharmaceutical industry in China, 2006-2013
Figure 3-6 Performance of China’s pharmaceutical circulation, 2006-2013
Figure 3-7 Terminal medicine market size in China, 2007-2013
Figure 3-8 Sub-market structure of pharmaceutical industry in China in terms of value (at retail level), 2007-2013
Figure 3-9 Terminal medical treatment market size in China, 2007-2013
Figure 3-10 Market share of key categories in China’s chemical pharmaceuticals in terms of value (hospital terminate), 2007-2013
Figure 3-11 Market share of key categories in China’s TCM preparations in terms of value (hospital terminate), 2007-2013
Figure 3.1-1 Total revenue of top 100 companies and their share in gross sales of China's pharmaceutical industry, 2009-2013
Figure 3.1-2 Scale distribution of top 100 companies in China’s pharmaceutical industry in terms of revenue, 2012-2013
Figure 3.3-1 Gross sales of China’s pharmaceutical circulation industry, 2008-2013
Figure 3.3-2 Structure (sub-market level) of pharmaceutical market in China in terms of sales value, 2013
Figure 3.3-3 Structure of pharmaceutical market in China in terms of sales value at retail pharmacy level, 2013
Figure 3.3-4 Geographical distribution of pharmaceuticals sales in China in terms of sales value, 2013
Figure 3.3-5 Ownership structure of enterprises in China in terms of revenue, 2013
Figure 3.3-6 Distribution structure of pharmaceuticals in terms of value of distributed pharmaceuticals, 2013
Figure 3.3-7 Medicine circulation of direct-reporting enterprises in China, 2012-2013
Figure 3.3-8 Share of revenue of different scale medicine wholesale enterprises in the total of pharmaceutical market in China, 2011-2013
Figure 3.3-9 Number of key medicine wholesale enterprises in China in terms of revenue, 2011-2013
Figure 3.4-1 Pharmaceutical R&D expenditures by the public sector and private industry in China, 2007-2012
Figure 3.4-2 Compound annual growth rate (2006-2012) of pharmaceutical R&D expenditures of some countries/regions
Figure 4.2-1 Supply chain of pharmaceuticals in China
Figure 4.2-2 Number of participants in the supply chain of medicine in China, 2013
Figure 4.2-3 Number of wholesale enterprises and retail chain enterprises of medicine in China, 2009-2012
Figure 4.2-4 Number of retail pharmacies in China, 2008-2012
Figure 4.2-5 Market share of retail terminal and other terminals in China, 2007-2013
Figure 4.2-6 Number of provincial pharmacy leagues in China, 2009-2013
Figure 4.2-7 Gross sales of provincial pharmacy leagues in China, 2010-2013
Figure 4.2-8 Medicine enterprises (with license) and market size of E-commerce of medicine in China, 2010-2013
Figure 4.3-1 Number of listed companies in pharmaceutical industry in China by sub-market, 2013
COMPANIES MENTIONED
Guangzhou Pharmaceutical Holding Limited
Xiuzheng Pharmaceutical Group
Yangtze River Pharmaceutical Group
China Resources Pharmaceutical Group Limited
China National Pharmaceutical Group Corporation
Figure 1-1 China’s GDP and year-on-year growth rate, 2004-2013
Figure 1-2 China’s foreign trade, 2004-2013
Figure 1-3 Total investment in fixed assets in China, 2004-2013
Figure 1-4 Investment in fixed assets under construction and newly built (farmers excluded) in China, 2004-2012
Figure 1-5 Foreign capital actually utilized in China, 2004-2013
Figure 1-6 China’s outward foreign direct investment (financing excluded), 2008-2013
Figure 1-7 China’s population, 2004-2013
Figure 1-8 China’s demographic composition, 2004-2013
Figure 1-9 Per capita income of residents in China, 2004-2013
Figure 1-10 Total health expenditure in China, 2004-2013
Figure 1-11 Per capita health expenditure in China, 2004-2012
Figure 2-1 Morbidity and mortality of infectious diseases in China, 2004-2013
Figure 2-2 Top 10 countries/regions of diabetes in the world in terms of number of diabetic, 2013
Figure 3-1 Gross industrial output of pharmaceutical industry in China, 2006-2013
Figure 3-2 Global pharmaceuticals sales and its growth rate, 2004-2013
Figure 3-3 Structure of gross industrial output of pharmaceutical industry in China, 2013
Figure 3-4 Sales revenue of pharmaceutical industry in China, 2006-2013
Figure 3-5 Profit and profit margin of pharmaceutical industry in China, 2006-2013
Figure 3-6 Performance of China’s pharmaceutical circulation, 2006-2013
Figure 3-7 Terminal medicine market size in China, 2007-2013
Figure 3-8 Sub-market structure of pharmaceutical industry in China in terms of value (at retail level), 2007-2013
Figure 3-9 Terminal medical treatment market size in China, 2007-2013
Figure 3-10 Market share of key categories in China’s chemical pharmaceuticals in terms of value (hospital terminate), 2007-2013
Figure 3-11 Market share of key categories in China’s TCM preparations in terms of value (hospital terminate), 2007-2013
Figure 3.1-1 Total revenue of top 100 companies and their share in gross sales of China's pharmaceutical industry, 2009-2013
Figure 3.1-2 Scale distribution of top 100 companies in China’s pharmaceutical industry in terms of revenue, 2012-2013
Figure 3.3-1 Gross sales of China’s pharmaceutical circulation industry, 2008-2013
Figure 3.3-2 Structure (sub-market level) of pharmaceutical market in China in terms of sales value, 2013
Figure 3.3-3 Structure of pharmaceutical market in China in terms of sales value at retail pharmacy level, 2013
Figure 3.3-4 Geographical distribution of pharmaceuticals sales in China in terms of sales value, 2013
Figure 3.3-5 Ownership structure of enterprises in China in terms of revenue, 2013
Figure 3.3-6 Distribution structure of pharmaceuticals in terms of value of distributed pharmaceuticals, 2013
Figure 3.3-7 Medicine circulation of direct-reporting enterprises in China, 2012-2013
Figure 3.3-8 Share of revenue of different scale medicine wholesale enterprises in the total of pharmaceutical market in China, 2011-2013
Figure 3.3-9 Number of key medicine wholesale enterprises in China in terms of revenue, 2011-2013
Figure 3.4-1 Pharmaceutical R&D expenditures by the public sector and private industry in China, 2007-2012
Figure 3.4-2 Compound annual growth rate (2006-2012) of pharmaceutical R&D expenditures of some countries/regions
Figure 4.2-1 Supply chain of pharmaceuticals in China
Figure 4.2-2 Number of participants in the supply chain of medicine in China, 2013
Figure 4.2-3 Number of wholesale enterprises and retail chain enterprises of medicine in China, 2009-2012
Figure 4.2-4 Number of retail pharmacies in China, 2008-2012
Figure 4.2-5 Market share of retail terminal and other terminals in China, 2007-2013
Figure 4.2-6 Number of provincial pharmacy leagues in China, 2009-2013
Figure 4.2-7 Gross sales of provincial pharmacy leagues in China, 2010-2013
Figure 4.2-8 Medicine enterprises (with license) and market size of E-commerce of medicine in China, 2010-2013
Figure 4.3-1 Number of listed companies in pharmaceutical industry in China by sub-market, 2013
COMPANIES MENTIONED
Guangzhou Pharmaceutical Holding Limited
Xiuzheng Pharmaceutical Group
Yangtze River Pharmaceutical Group
China Resources Pharmaceutical Group Limited
China National Pharmaceutical Group Corporation
